Literature DB >> 27138574

Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India.

Chhavi Gupta1, Marit Jongman2, Shukla Das3, K Snehaa1, S N Bhattacharya4, S Seyedmousavi5,6,7, Anne D van Diepeningen2.   

Abstract

Onychomycosis refers to fungal infection of the nail and is commonly caused by dermatophytes, while yeasts and non-dermatophytic molds (NDM) are increasingly recognized as pathogens in nail infections. The present study was done to delineate molecular epidemiology of Fusarium onychomycosis in India. Five hundred nail samples of Indian patients clinically suspected of onychomycosis were subjected to direct microscopy and fungal culture. Representative Fusarium isolates were further identified to species level by multi-locus sequencing for internal transcribed spacer, translation elongation factor 1 alpha (tef1-α) and RNA polymerase II subunit (rpb2) regions (primer pairs: ITS1/ITS4, EF1/EF2, 5f2/7cr, respectively). These representative strains were also tested for in vitro antifungal susceptibility by the broth microdilution method. Members of the genus Fusarium proved to be the most common NDM responsible for onychomycosis. The Fusarium spp. responsible for onychomycosis belonged to the Fusarium solani species complex (F. keratoplasticum and F. falciforme) and Fusarium fujikuroi species complex (F. proliferatum, F. acutatum and F. sacchari). Antifungal susceptibility results indicated that amphotericin B was the most effective antifungal across all isolates (MIC ranging 0.5-2 mg/L), followed by voriconazole (MIC ranging 1-8 µg/ml). However, a large variation was shown in susceptibility to posaconazole (MIC ranging 0.5 to >16 µg/ml). To conclude, we identified different Fusarium spp. responsible for onychomycosis in India with variation within species in susceptibility to antifungal agents, showing that fusariosis requires correct and prompt diagnosis as well as antifungal susceptibility testing.

Entities:  

Keywords:  Fusariosis; Fusarium fujikuroi species complex (FFSC); Fusarium sacchari; Fusarium solani species complex (FSSC); Onychomycosis

Mesh:

Substances:

Year:  2016        PMID: 27138574     DOI: 10.1007/s11046-016-0014-7

Source DB:  PubMed          Journal:  Mycopathologia        ISSN: 0301-486X            Impact factor:   2.574


  28 in total

1.  Fusarium sacchari: a cause of exogenous fungal endophthalmitis: first case report and review of literature.

Authors:  Jagdish Chander; Nidhi Singla; Neelam Gulati; Sunandan Sood
Journal:  Mycopathologia       Date:  2010-10-24       Impact factor: 2.574

2.  Onychomycosis: Clinico-mycologic study of 130 patients from Himachal Pradesh, India.

Authors:  Mudita Gupta; Nand Lal Sharma; Anil K Kanga; Vikram K Mahajan; Gita Ram Tegta
Journal:  Indian J Dermatol Venereol Leprol       Date:  2007 Nov-Dec       Impact factor: 2.545

Review 3.  Onychomycosis of toenails: orthopaedic and podiatric considerations.

Authors:  Stuart C Murray; Rodney P R Dawber
Journal:  Australas J Dermatol       Date:  2002-05       Impact factor: 2.875

4.  Gangrenous necrosis of the diabetic foot caused by Fusarium acutatum.

Authors:  Saad J Taj-Aldeen; Josepa Gene; Issam Al Bozom; Walter Buzina; José Francisco Cano; Josep Guarro
Journal:  Med Mycol       Date:  2006-09       Impact factor: 4.076

5.  Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex.

Authors:  Abdullah M S Al-Hatmi; Anne D van Diepeningen; Ilse Curfs-Breuker; G Sybren de Hoog; Jacques F Meis
Journal:  J Antimicrob Chemother       Date:  2014-12-23       Impact factor: 5.790

Review 6.  Onychomycosis--epidemiology, diagnosis and management.

Authors:  R Kaur; B Kashyap; P Bhalla
Journal:  Indian J Med Microbiol       Date:  2008 Apr-Jun       Impact factor: 0.985

Review 7.  Treatment of nondermatophyte mold and Candida onychomycosis.

Authors:  Antonella Tosti; Bianca Maria Piraccini; Sandra Lorenzi; Matilde Iorizzo
Journal:  Dermatol Clin       Date:  2003-07       Impact factor: 3.478

8.  Molecular phylogenetic diversity of dermatologic and other human pathogenic fusarial isolates from hospitals in northern and central Italy.

Authors:  Quirico Migheli; Virgilio Balmas; Henry Harak; Silvana Sanna; Barbara Scherm; Takayuki Aoki; Kerry O'Donnell
Journal:  J Clin Microbiol       Date:  2010-01-27       Impact factor: 5.948

9.  MrBayes 3.2: efficient Bayesian phylogenetic inference and model choice across a large model space.

Authors:  Fredrik Ronquist; Maxim Teslenko; Paul van der Mark; Daniel L Ayres; Aaron Darling; Sebastian Höhna; Bret Larget; Liang Liu; Marc A Suchard; John P Huelsenbeck
Journal:  Syst Biol       Date:  2012-02-22       Impact factor: 15.683

10.  Onychomycosis due to nondermatophytic molds.

Authors:  Sung Min Hwang; Moo Kyu Suh; Gyoung Yim Ha
Journal:  Ann Dermatol       Date:  2012-04-26       Impact factor: 1.444

View more
  7 in total

1.  A chloroacetamide derivative as a potent candidate for fusariosis treatment.

Authors:  Gabriella da Rosa Monte Machado; Stefânia Neiva Lavorato; William Lopes; Marilene Henning Vainstein; Mário Lettieri Teixeira; Ricardo José Alves; Saulo Fernandes de Andrade; Alexandre Meneghello Fuentefria
Journal:  Braz J Microbiol       Date:  2022-06-01       Impact factor: 2.214

Review 2.  Epidemiology of fungal infections in China.

Authors:  Min Chen; Yuan Xu; Nan Hong; Yali Yang; Wenzhi Lei; Lin Du; Jingjun Zhao; Xia Lei; Lin Xiong; Langqi Cai; Hui Xu; Weihua Pan; Wanqing Liao
Journal:  Front Med       Date:  2018-01-11       Impact factor: 4.592

3.  Epidemiology of Onychomycosis in an Academic Nail Unit in South Greece during a Three-Year Period.

Authors:  Stamatios Gregoriou; Nikoletta Mpali; Georgia Vrioni; Eleni Hatzidimitriou; Stella-Eugenia Chryssou; Dimitrios Rigopoulos
Journal:  Skin Appendage Disord       Date:  2019-12-19

4.  Molecular characterization and antifungal activity against non-dermatophyte molds causing onychomycosis.

Authors:  Keyvan Pakshir; Mandana Kamali; Hasti Nouraei; Kamiar Zomorodian; Marjan Motamedi; Mozhgan Mahmoodi
Journal:  Sci Rep       Date:  2021-10-20       Impact factor: 4.379

5.  In Vitro Antifungal Susceptibility Profile of Miltefosine against a Collection of Azole and Echinocandins Resistant Fusarium Strains.

Authors:  Mohsen Nosratabadi; Javad Akhtari; Leila Faeli; Iman Haghani; Seyed Reza Aghili; Tahereh Shokohi; Mohammad Taghi Hedayati; Hossein Zarrinfar; Rasoul Mohammadi; Mohammad Javad Najafzadeh; Sadegh Khodavaisy; Ahmed Al-Harrasi; Mohammad Javan-Nikkhah; Reza Kachuei; Maryam Salimi; Mahsa Fattahi; Hamid Badali; Abdullah M S Al Hatmi; Mahdi Abastabar
Journal:  J Fungi (Basel)       Date:  2022-07-04

Review 6.  Reduced Multidrug Susceptibility Profile Is a Common Feature of Opportunistic Fusarium Species: Fusarium Multi-Drug Resistant Pattern.

Authors:  Saad J Taj-Aldeen
Journal:  J Fungi (Basel)       Date:  2017-04-10

7.  Biofilm Formation and Resistance to Fungicides in Clinically Relevant Members of the Fungal Genus Fusarium.

Authors:  Hafize Sav; Haleh Rafati; Yasemin Öz; Burcu Dalyan-Cilo; Beyza Ener; Faezeh Mohammadi; Macit Ilkit; Anne D van Diepeningen; Seyedmojtaba Seyedmousavi
Journal:  J Fungi (Basel)       Date:  2018-01-23
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.